News
A group of University of Kentucky professors and scientists efforts to identify possible direct therapeutic approaches to treat COVID-19 was published in the Perspectives section of the most recent issue of Science, a journal of the American Association for the Advancement of Science (AAAS).
Lung cancer is a complex and devastating disease, especially in the Commonwealth. In fact, Kentuckians are twice as likely as the rest of U.S. citizens to develop squamous cell carcinoma and small-cell lung cancer, both of which are very serious cancers that typically have low survival rates.
Leonard (Leo) Yenwongfai was just 5 years old when he officially solidified his plans to become a doctor. It was after a conversation he had with a physician who was taking care of a family member at the time. That man, also named Leonard, told him, “I want you to be a doctor just like me.”
In response to the COVID-19 pandemic, the University of Kentucky Center for Clinical and Translational Science (CCTS) has created a new biospecimen bank to support research on the novel virus. Logistical support for the biobank is led by the UK Markey Cancer Center.
As the worldwide coronavirus COVID-19 pandemic continues to play out, researchers are among those working to find innovative solutions to help flatten the curve.
One such researcher is Jamie Sturgill, assistant professor in the University of Kentucky College of Medicine Department of Internal Medicine. Sturgill's research focuses heavily on lung disease.
Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, co-authored a paper reporting the first human clinical study of a drug candidate that suppresses injury and disease-induced inflammation of the brain.
University of Kentucky virologist Rebecca Dutch normally studies the steps of infection for viruses like human metapneumovirus, but she's been looking at the novel coronavirus these days. The chair of UK’s Department of Molecular & Cellular Biochemistry is leading the College of Medicine’s COVID-19 Unified Research Experts (CURE) Alliance team, which brings together faculty expertise from multiple disciplines across the university to focus on advising COVID-19 patient care and clinical trials based on emerging research. Today, she answers some of our questions about COVID-19.
Timothy Ainger, PhD, had just completed a 10-hour clinic day when he pulled out his cellphone to check his messages. There were 74 in total, which was pretty typical because he was involved in group chats with his pals, as well as a Fantasy Football league. However, amid those messages were 14 notifications from his wife, Jan.
Researchers and faculty from multiple disciplines across the University of Kentucky are coming together as part of the global effort to treat, understand and eradicate COVID-19.
The COVID-19 Unified Research Experts (CURE) Alliance team, a new workgroup within UK’s College of Medicine, is bringing together UK experts from across the campus to focus on advising COVID-19 patient care and clinical trials based on emerging research and potential treatment options.
Next week, the University of Kentucky College of Medicine and the Department of Chemistry in the UK College of Arts and Sciences will host renowned biochemist Dr. Rafael Radi for two special events on campus.
As a young student who was proficient in science, Dr. Eseosa Ighodaro, always saw herself pursuing a career in medicine. But it wasn’t until applying to medical school that she discovered there was another path she wanted to follow.
University of Kentucky College of Medicine researcher Ann Stowe describes her career path as nontraditional. After earning a bachelor’s degree in fine arts, Stowe decided to pursue graduate study in biomedical research instead of art history.
Today, the associate professor in UK’s Department of Neurology studies how the brain recovers from stroke. The same passion for creativity that attracted Stowe to studying the arts is what drives her in the laboratory.
Today, University of Kentucky officials provided updates on the recently launched Kentucky Viral Hepatitis Treatment Project (KeY Treat), a three-year, $15 million study co-funded by the National Cancer Institute (NCI) and National Institute on Drug Abuse (NIDA) with the ultimate goal of eradicating the hepatitis C virus (HCV) in Perry County, Kentucky.
The University of Kentucky College of Medicine’s Department of Family and Community Medicine’s Primary Care Training Enhancement (PCTE) grant team was recently selected to receive the Outstanding Educational Program Award by the Association for Prevention Teaching and Research (APTR). This award honors an innovative program, department, or academic institution for their involvement in advancing undergraduate or graduate medical education in prevention and public health which furthers students’ interest in the discipline.
An international group of experts led by Dr. Peter Nelson, a neuropathologist at the University of Kentucky Sanders-Brown Center on Aging, is being recognized as one of the top science stories of 2019 by Discover Magazine.
Researchers at the University of Kentucky’s College of Medicine have found that a class of antibiotics called aminoglycosides could be a promising treatment for frontotemporal dementia.
Results of their proof of concept study, which was a collaborative effort between UK’s Department of Molecular and Cellular Biochemistry and the University of California San Francisco’s Department of Pathology, were recently published in the journal, Human Molecular Genetics.
New research shows that the microorganisms in our gut could help protect brain cells from damage caused by inflammation after a stroke.
The study, published in the Journal of Neuroscience by researchers from the Ludwig Maximilian University of Munich, University of Kentucky’s College of Medicine and University of Texas Southwestern Medical Center reveals that supplementing the body’s short chain fatty acids could improve stroke recovery.